Biotech Values

[mcbio]

Dew, iwfal, or others:

I didn't realize when I first posted about this that Oncogenex is publicly traded (OGXI). I think a really interesting question, given OGXI's tiny market cap of $25 million and the trial results, is whether or not OGXI warrants further scrutiny as a possible investment.

They are going to need to raise cash via partnership to further develop OGX-011 but, given how good these results appear, I would think that's quite possible/probable. There's always the possibility of a buyout from someone as well.

Any thoughts?

Thanks.